Join Lachman Consultants at this year’s FDLI Annual Conference in Washington, DC, May 17 –18, 2023, for a two-day hybrid event that will address complex legal, regulatory, compliance, and policy issues in all facets of the FDA-regulated industry. Lachman Consultants will be represented by:

  • Martin Shimer (Executive Director)
  • Rachel Thompson, JD (Senior Director)
  • David Petshaft, Esq. (Chief Legal and Financial Officer)
  • Jessica Soderberg, Esq. (Corporate Counsel)
  • Matt Taylor (Director, Marketing & Client Engagement)

A premier conference for the food and drug law community, the FDLI annual event brings together hundreds of renowned officials and experts who will share their knowledge and insights on the latest legal, regulatory, compliance, policy, and government issues, challenges, and trends.

Lachman Consultants is excited to showcase its extensive experience in handling CGMP matters, with deep expertise specifically in areas such as data integrity, assistance in handling responses to 483s/warning letters, import alerts, providing valuable subject matter expert advice on regulatory matters and more. During the conference, we will be actively participating and available to meet and discuss the importance of quality, completeness, attention to detail, and data integrity in the FDA-regulated industry, as well as other industry-related matters, and how Lachman Consultants can partner with you to navigate the ongoing legal and regulatory complexities.

The Food and Drug Law Institute (FDLI) is a non-profit membership organization that provides education, training, publications, and professional engagement opportunities in the area of food

and drug law. Serving as one of the premier industry organizations in the area of food and drug law, FDLI offers a platform for stakeholders to inform on matters of current innovative public policy, law, and regulation.

Don’t miss this opportunity to network, build relationships, and gain new insights and strategies to address the constantly evolving legal, regulatory, and compliance landscape in the FDA-regulated industry.

For more information about the 2023 FDLI Annual Conference, click here.